RELMADA THERAPEUTICS, INC.

Profile

Company Names

RELMADA THERAPEUTICS, INC.
CAMP NINE, INC.

Addresses

880 3RD AVENUE, 12TH FLOOR, NEW YORK, NY 10022

880 THIRD AVENUE, 12TH FLOOR, NEW YORK, NY 10022

750 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY 10017

750 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY 10017

546 FIFTH AVENUE, 14TH FLOOR, NEW YORK, NY 10036

Phone Numbers

646 876 3459
212-547-9591
(212) 702-7163

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

NEVADA

Total Amount Raised:

$36,091,687.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-09-23 
$825,750.00 
$825,750.00 
$0.00 
Equity 
6
2019-06-14 
$8,432,437.00 
$10,000,000.00 
$1,567,563.00 
Equity 
5
2019-05-14 
$3,414,505.00 
$10,000,000.00 
$6,585,495.00 
Equity 
4
2018-10-12 
$5,834,407.00 
$10,000,000.00 
$4,165,593.00 
Equity 
3
2017-09-28 
$6,890,000.00 
$6,890,000.00 
$0.00 
Debt 
2
2014-06-10 
$10,694,588.00 
$10,694,588.00 
$0.00 
Equity 
1
2014-05-20 
$0.00 
$0.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHREERAM 
 
AGHARKAR 
DIRECTOR
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.
DOUGLAS 
 
BECK 
EXECUTIVE OFFICER
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.   |  SHIFTPIXY, INC.
CHARLES 
 
CASAMENTO 
DIRECTOR
INTERNATIONAL STEM CELL CORP   |  AZURRX BIOPHARMA, INC.   |  ETON PHARMACEUTICALS, INC.   |  RELMADA THERAPEUTICS, INC.   |  FIRST WAVE BIOPHARMA, INC.   |  GT BIOPHARMA, INC.
CHUCK 
 
ENCE 
EXECUTIVE OFFICER
RELMADA THERAPEUTICS, INC.
PAUL 
 
KELLY 
DIRECTOR
SURNA INC.   |  RELMADA THERAPEUTICS, INC.   |  BLACKSTONE / GSO SECURED TRUST FEEDER LP   |  GSO EUROPEAN SENIOR DEBT FUND II LEVERED EEA FEEDER SCSP   |  GSO EUROPEAN SENIOR DEBT FUND II LEVERED EEA SCSP   |  GSO EUROPEAN SENIOR DEBT FEEDER FUND II LP   |  GSO EUROPEAN SENIOR DEBT FUND II LP   |  GSO EUROPEAN SENIOR DEBT FUND II EEA FEEDER SCSP   |  GSO EUROPEAN SENIOR DEBT FUND II EEA SCSP   |  BABEL BARK, INC.   |  BLACKSTONE CLO OPPORTUNITY OVERSEAS FUND LP   |  BLACKSTONE CLO OPPORTUNITY FUND LP   |  BLACKSTONE CAPITAL OPPORTUNITIES FUND IV LP   |  BLACKSTONE CAPITAL OPPORTUNITIES FUND IV EEA SCSP   |  BLACKSTONE CAPITAL OPPORTUNITIES FUND IV EEA FEEDER SCSP   |  BLACKSTONE CAPITAL OPPORTUNITIES FEEDER FUND IV LP   |  BLACKSTONE COF IV CO-INVESTMENT FEEDER FUND EEA SCSP   |  BLACKSTONE COF IV CO-INVESTMENT FUND EEA SCSP   |  BLACKSTONE COF IV CO-INVESTMENT FEEDER FUND LP   |  BLACKSTONE COF IV CO-INVESTMENT FUND LP   |  BIVACOR INC.   |  ENZETA IMMUNOTHERAPIES, INC.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (U) I RN, L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (U ONSHORE), L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (U OFFSHORE), LIMITED PARTNERSHIP   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (U OFFSHORE DE), L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (U) II RN, LP   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (U) III RN L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (U) IV RN L.P.   |  BAIN CAPITAL SENIOR LOAN FUND, L.P.   |  BAIN CAPITAL SENIOR LOAN FUND (SRI), L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (ONSHORE), L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (OFFSHORE), L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (OFFSHORE DE), L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (OFFSHORE DE-C), L.P.   |  BAIN CAPITAL GLOBAL DIRECT LENDING FUND (OFFSHORE C), L.P.   |  BAIN CAPITAL HIGH INCOME PARTNERSHIP, L.P.
ELISEO 
O. 
SALINAS 
EXECUTIVE OFFICER
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.
SANDESH 
 
SETH 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.
MAGED 
 
SHENOUDA 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.   |  AZURRX BIOPHARMA, INC.   |  RELMADA THERAPEUTICS, INC.
SERGIO 
 
TRAVERSA 
EXECUTIVE OFFICER, DIRECTOR
ARDANA HEALTHCARE FUND LP   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.   |  ENZETA IMMUNOTHERAPIES, INC.
OTTAVIO 
 
VITOLO 
EXECUTIVE OFFICER
RELMADA THERAPEUTICS, INC.
NABIL 
M. 
YAZGI 
DIRECTOR
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-10-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-09-23 
2019-07-10
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-06-14 
2019-06-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-06-14 
2019-05-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-05-14 
2018-12-10
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2018-10-12 
2018-11-13
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2018-10-12 
2018-10-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2018-10-12 
2017-10-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2017-09-28 
2014-06-19
D
Link
BIOTECHNOLOGY 
[3949] 
NO REVENUES 
Equity 
2014-06-10 
2014-06-04
D
Link
BIOTECHNOLOGY 
[3949] 
NO REVENUES 
Equity 
2014-05-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE
NONE
NONE
ALEXANDER CAPITAL, LP
40077
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF ARCADIA SECURITIES, LLC
44656
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF CIM SECURITIES, LLC
120852
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037